Zenotech Laboratories has received approval from the US Food and Drug Administration (USFDA) for its ondansetron injection, a copy of Glaxosmithkline Plc’s Zofran anti-nausea medicine.
Zenotech develops and manufactures generic bio-pharmaceuticals and markets them to people with unmet medical needs around the world. The company aims to bring a constant pipeline of new biogeneric products to the market. The highly qualified and trained staff uses recombinant DNA technology and cGMP production methods to give the customers generic versions of biotherapeutic drugs comparable to the innovator product in quality, safety and efficacy.
